Effects of Transcranial Temporal Interference Stimulation on Risky Decision-making and Impulse Control in Gambling Disorder

Launched by SHANGHAI MENTAL HEALTH CENTER · Jun 20, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new treatment method called transcranial temporal interference stimulation (tTIS) to see how it affects decision-making and impulse control in people with gambling disorder. The treatment specifically targets a part of the brain called the dorsal anterior cingulate cortex, which is involved in making choices and controlling urges. Researchers want to understand if this method can help people who struggle with gambling by improving their ability to make better decisions and resist the urge to gamble.

To participate in this study, individuals need to be between 18 and 60 years old, male, and right-handed. They should have a history of gambling for at least a year and meet specific criteria for gambling addiction. Participants will need to complete questionnaires and behavioral tests. It's important to note that those with certain medical conditions, such as severe cognitive issues or a history of neurological problems, will not be eligible. Because the study is not yet recruiting, interested individuals will need to wait for more information on how to join.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Aged 18-60, male or female, right handed;
• • With 9 or more years of education, and able to cooperate in completing the questionnaire assessment and behavioural tests.
• • Meets the DSM-5 diagnostic criteria for gambling addiction;
• • Previous gambling behaviour of not less than 1 year's duration (at least one gambling session per week or more);
• • Normal or corrected normal vision and hearing;
• • Agrees to cooperate in completing the follow-up assessment;
• • No history of neurological problems or head injury; and no skin sensitivity.
• • Agree to cooperate in completing the follow-up assessment;
• • No metal implantation in the head, no history of neurological problems or head injury, and no skin sensitivity.
• Exclusion Criteria:
• • Suffering from severe cognitive dysfunction, such as a history of head trauma, cerebrovascular disease, epilepsy, etc., use of cognitive-promoting medications in the last 6 months;
• • Other psychoactive substance abuse or dependence in the last 5 years (except nicotine).